Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis

Introduction and objectives Epicardial and mediastinal adipose tissue (EAT, MAT) are linked to metabolic syndrome and coronary artery disease. Patients with chronic kidney disease (CKD) have thicker EAT. We assessed if EAT and MAT could be associated with increased mortality and cardiovascular event...

Descripción completa

Detalles Bibliográficos
Autores: Cano Megías, Marta, Guisado Vasco, Pablo, Bouarich, Hanane, Lara Aguilera, Isabel, Arriba de la Fuente, Gabriel de, Rodríguez Puyol, Diego
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad Europea (UEM)
Repositorio:ABACUS. Repositorio de Producción Científica
Idioma:inglés
OAI Identifier:oai:abacus.universidadeuropea.com:11268/11388
Acceso en línea:http://hdl.handle.net/11268/11388
Access Level:acceso abierto
Palabra clave:Diabetes mellitus tipo 2
Calcificación vascular
Fallo renal crónico
Enfermedad cardiovascular
Sistema endocrino
id ES_0f8f6eaae4f3e51a52f2fbbbfabbce9d
oai_identifier_str oai:abacus.universidadeuropea.com:11268/11388
network_acronym_str ES
network_name_str España
spelling Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis Tejido graso epicárdico, calcificación arterial coronaria y mortalidad en pacientes con enfermedad renal crónica avanzada y hemodiálisis Cano Megías, Marta Guisado Vasco, Pablo Bouarich, Hanane Lara Aguilera, Isabel Arriba de la Fuente, Gabriel de Rodríguez Puyol, Diego Diabetes mellitus tipo 2 Calcificación vascular Fallo renal crónico Enfermedad cardiovascular Sistema endocrino Introduction and objectives Epicardial and mediastinal adipose tissue (EAT, MAT) are linked to metabolic syndrome and coronary artery disease. Patients with chronic kidney disease (CKD) have thicker EAT. We assessed if EAT and MAT could be associated with increased mortality and cardiovascular events in patients with advanced CKD and haemodialysis therapy. Methods A post-hoc study was performed. We analyzed a prospective series of 104 cases. EAT thickness was quantified by a multislice synchronized computed tomography (MSCT). Results The follow-up period was 112.68 (109.94–115.42) months. The optimal cut-off point of EAT for prediction of total mortality was 11.45 mm (92.86% and 43.75%). EAT thickness was associated with serum albumin levels, serum triglyceride levels, phosphorus and calcium phosphate product. The EAT was greater in haemodialysis patients compared to those with advanced CKD (P < .001). Patients with diabetes mellitus had greater EAT and MAT thickness (P = .018). At the end of follow up, the survival average time of patients with EAT thickness <11.45 mm was 97.48 months vs. 76.65 months for thickness > 11.45 mm (P = .007). Conclusions A higher EAT and MAT thickness was associated with increased mortality. Furthermore, EAT was associated with lower free survival time to fatal and non-fatal cardiovascular events. The measurement of EAT and MAT by MSCT could be a prognostic tool to predict cardiovascular events and mortality risk in advanced CKD patients. http://hdl.handle.net/11268/11388
title Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis
spellingShingle Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis
Cano Megías, Marta
Diabetes mellitus tipo 2
Calcificación vascular
Fallo renal crónico
Enfermedad cardiovascular
Sistema endocrino
title_short Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis
title_full Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis
title_fullStr Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis
title_full_unstemmed Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis
title_sort Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis
author Cano Megías, Marta
author_facet Cano Megías, Marta
Guisado Vasco, Pablo
Bouarich, Hanane
Lara Aguilera, Isabel
Arriba de la Fuente, Gabriel de
Rodríguez Puyol, Diego
author_role author
author2 Guisado Vasco, Pablo
Bouarich, Hanane
Lara Aguilera, Isabel
Arriba de la Fuente, Gabriel de
Rodríguez Puyol, Diego
author2_role author
author
author
author
author
topic Diabetes mellitus tipo 2
Calcificación vascular
Fallo renal crónico
Enfermedad cardiovascular
Sistema endocrino
topic_facet Diabetes mellitus tipo 2
Calcificación vascular
Fallo renal crónico
Enfermedad cardiovascular
Sistema endocrino
description Introduction and objectives Epicardial and mediastinal adipose tissue (EAT, MAT) are linked to metabolic syndrome and coronary artery disease. Patients with chronic kidney disease (CKD) have thicker EAT. We assessed if EAT and MAT could be associated with increased mortality and cardiovascular events in patients with advanced CKD and haemodialysis therapy. Methods A post-hoc study was performed. We analyzed a prospective series of 104 cases. EAT thickness was quantified by a multislice synchronized computed tomography (MSCT). Results The follow-up period was 112.68 (109.94–115.42) months. The optimal cut-off point of EAT for prediction of total mortality was 11.45 mm (92.86% and 43.75%). EAT thickness was associated with serum albumin levels, serum triglyceride levels, phosphorus and calcium phosphate product. The EAT was greater in haemodialysis patients compared to those with advanced CKD (P < .001). Patients with diabetes mellitus had greater EAT and MAT thickness (P = .018). At the end of follow up, the survival average time of patients with EAT thickness <11.45 mm was 97.48 months vs. 76.65 months for thickness > 11.45 mm (P = .007). Conclusions A higher EAT and MAT thickness was associated with increased mortality. Furthermore, EAT was associated with lower free survival time to fatal and non-fatal cardiovascular events. The measurement of EAT and MAT by MSCT could be a prognostic tool to predict cardiovascular events and mortality risk in advanced CKD patients.
publishDate 2021
format article
url http://hdl.handle.net/11268/11388
language eng
eu_rights_str_mv openAccess
institution Universidad Europea (UEM)
collection ABACUS. Repositorio de Producción Científica
reponame_str ABACUS. Repositorio de Producción Científica
instname_str Universidad Europea (UEM)
_version_ 1878431508908212224
publishDateSort 2021
author_browse Arriba de la Fuente, Gabriel de
Bouarich, Hanane
Cano Megías, Marta
Guisado Vasco, Pablo
Lara Aguilera, Isabel
Rodríguez Puyol, Diego
score 6,9303427

Similares en LA Referencia